Association Between BoLA-DRB3.2 Polymorphism and Bovine Papillomavirus Infection for Bladder Tumor Risk in Podolica Cattle.
DRB3 exon 2 (DRB3.2)
E5 oncoprotein
bovine leukocyte antigen (BoLA)
bovine papilloma virus type 2
major histocompatibility complex class II (MHC II)
Journal
Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
11
2020
accepted:
21
04
2021
entrez:
28
6
2021
pubmed:
29
6
2021
medline:
29
6
2021
Statut:
epublish
Résumé
Blood samples from 260 unrelated cattle (132 animals affected by papillomavirus-associated bladder tumors and 128 healthy) were genotyped using the classic polymerase chain reaction/restriction fragment length polymorphism method to screen MHC class II bovine leukocyte antigen-DRB3. 2 polymorphism. The DRB3
Identifiants
pubmed: 34179154
doi: 10.3389/fvets.2021.630089
pmc: PMC8219868
doi:
Types de publication
Journal Article
Langues
eng
Pagination
630089Informations de copyright
Copyright © 2021 Longeri, Russo, Strillacci, Perillo, Carisetti, Cozzi, Neola and Roperto.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Vet Pathol. 1976;13(2):110-22
pubmed: 945629
J Virol. 2009 May;83(9):4039-50
pubmed: 19211750
Vet Microbiol. 2016 Jul 15;190:1-4
pubmed: 27283849
J Comp Pathol. 2010 Feb-Apr;142(2-3):95-108
pubmed: 19818448
Sci Rep. 2018 Sep 6;8(1):13310
pubmed: 30190493
Transbound Emerg Dis. 2018 Oct;65(5):1381-1395
pubmed: 29603890
Arch Med Res. 2011 Jul;42(5):421-5
pubmed: 21911185
ISRN Vet Sci. 2012 May 28;2012:872710
pubmed: 23738132
Biochem Biophys Res Commun. 2009 Jul 24;385(2):137-42
pubmed: 19422791
Immunogenetics. 1991;33(3):188-93
pubmed: 2010221
PLoS One. 2010 Apr 22;5(4):e10299
pubmed: 20421977
Vet Res. 2020 Jan 13;51(1):4
pubmed: 31931875
Anim Sci J. 2009 Oct;80(5):498-509
pubmed: 20163613
Virology. 1998 Jan 5;240(1):147-57
pubmed: 9448699
Nature. 1993 Jul 1;364(6432):33-9
pubmed: 8316295
Vet Microbiol. 2020 Nov;250:108879
pubmed: 33035817
Res Vet Sci. 2013 Aug;95(1):156-63
pubmed: 23541924
Retrovirology. 2019 May 16;16(1):14
pubmed: 31096993
Nat Genet. 1994 Feb;6(2):157-62
pubmed: 8162070
Int J Cancer. 2016 Aug 15;139(4):784-92
pubmed: 27037728
Virology. 2013 Oct;445(1-2):99-114
pubmed: 23731971
PLoS One. 2014 Feb 24;9(2):e88860
pubmed: 24586417
ScientificWorldJournal. 2012;2012:863024
pubmed: 22454612
Anim Genet. 2008 Aug;39(4):432-8
pubmed: 18573126
Oncogene. 2002 Nov 7;21(51):7808-16
pubmed: 12420217
J Exp Med. 1996 Mar 1;183(3):829-36
pubmed: 8642287
J Gen Virol. 2008 Dec;89(Pt 12):3027-3033
pubmed: 19008389
Transbound Emerg Dis. 2016 Dec;63(6):628-634
pubmed: 25597262
Cancer. 2012 Jan 1;118(1):223-31
pubmed: 21692064
Anim Sci J. 2009 Oct;80(5):510-9
pubmed: 20163614
Virus Genes. 2020 Oct;56(5):594-599
pubmed: 32638284
Vaccine. 2009 Dec 10;28(1):28-37
pubmed: 19833250
Mol Biol Evol. 2002 Jul;19(7):1022-5
pubmed: 12082122
J Comp Pathol. 2006 May;134(4):336-46
pubmed: 16714029
Vet Immunol Immunopathol. 2000 Oct 31;76(3-4):231-8
pubmed: 11044556
J Gen Virol. 2013 Feb;94(Pt 2):403-408
pubmed: 23100367
Infect Genet Evol. 2019 Mar;68:194-202
pubmed: 30590170
Anim Genet. 1992;23(6):483-96
pubmed: 1362859
Hum Immunol. 2019 Sep;80(9):723-730
pubmed: 31072753
J Immunol. 1993 Dec 15;151(12):6977-85
pubmed: 8258704
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7262-E7271
pubmed: 28808001
Oncogene. 2002 Jan 10;21(2):248-59
pubmed: 11803468
Nat Rev Cancer. 2007 Apr;7(4):295-308
pubmed: 17384584
PLoS One. 2018 Mar 1;13(3):e0193684
pubmed: 29494662
Vet Microbiol. 2019 Mar;230:95-100
pubmed: 30827412
Anim Genet. 1991;22(3):199-209
pubmed: 1928826
Nat Toxins. 1996;4(5):221-7
pubmed: 8946397
Sci Rep. 2019 Dec 13;9(1):19061
pubmed: 31836763
Cancer Res. 1992 Dec 15;52(24):6898-904
pubmed: 1333885
Rev Sci Tech. 1998 Apr;17(1):108-20
pubmed: 9638804